Work

PD-019 ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)

Year: 2016

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw200.19

Authors: V. Mazzaferro, W. Shaib, L. Rimassa, W. Harris, N. Personeni, B. El-Rayes, A. Tolcher, T. Hall, Y. Wang, B. Schwartz, J. Kazakin, M. Droz Dit Busset, C. Cotsoglou, K. Papadopoulos

Institutions: Fondazione IRCCS Istituto Nazionale dei Tumori, Emory University, Winship Cancer Institute, IRCCS Humanitas Research Hospital, University of Washington, South Texas Accelerated Research Therapeutics, Arqule (United States)

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

OpenAlex ID: W2469448980

FWCI: 1.999

Cites:

Cited by: 12

Related to: 10